Labile Copper Test Enhances Evaluation for Wilson's Disease: Joshua Bornhorst, Ph.D.

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/60/1c/db/601cdbab-e64e-5621-ea48-3f552af8ce81/mza_3523998437473959572.jpg/600x600bb.jpg

Answers from the Lab

Mayo Clinic Laboratories

368 episodes

1 day ago

A Mayo Clinic curated podcast sharing Mayo Clinic knowledge and advancements on the state of testing, science, and people who are making it happen behind the scenes.

All content for Answers from the Lab is the property of Mayo Clinic Laboratories and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

A Mayo Clinic curated podcast sharing Mayo Clinic knowledge and advancements on the state of testing, science, and people who are making it happen behind the scenes.

Medicine

Health & Fitness,

Science

https://img.transistor.fm/rV0qZYV6zivz4dZb59CqRE2vtZXMMil0KPGuaM6FMgE/rs:fill:3000:3000:1/q:60/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9iNTQ1/NjI1NGJiYzNiM2U4/NWRlMmE4YjdlZmM1/YzJjZC5qcGc.jpg

Labile Copper Test Enhances Evaluation for Wilson's Disease: Joshua Bornhorst, Ph.D.

Answers from the Lab

6 minutes

4 months ago

Labile Copper Test Enhances Evaluation for Wilson's Disease: Joshua Bornhorst, Ph.D.

Joshua Bornhorst, Ph.D., explains how Mayo Clinic Laboratories' labile copper assay (Mayo ID: LBCS) improves upon standard blood tests for Wilson's disease. The new test measures not just overall copper but also the fraction of copper that is bioavailable, or labile bound.

(00:32)
Can you tell us a little bit about yourself and your background?

(01:33)
Could you give us a brief overview of this assay?

(02:47)
Which patients should have this testing, and when should it be performed?

(03:48)
How would the results be used in patient care?